FindTrial
Sign In

Effect of perioperative administration of nesiritide on clinical outcome after cardiac surgery

Effect of perioperative administration of nesiritide on clinical outcome after cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067794
Enrollment
Unknown
Registered
2023-01-28
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac diseases

Interventions

Nesiritide group:Nesiritide
placebo group:none

Sponsors

Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing cardiac surgery; 2. Aged 0-80 years.

Exclusion criteria

Exclusion criteria: 1. Allergic to the new hormone; 2. The application time of the new hormone is less than 2 hours.

Design outcomes

Primary

MeasureTime frame
Low cardiac output syndrome;—

Secondary

MeasureTime frame
mortality;NT-proBNP change;—

Countries

China

Contacts

Public ContactTan Qi

Provincial Hospital Affiliated to Shandong First Medical University

deepblue1229@163.com+86 18753157303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026